期刊文献+

葛根素干预对糖尿病肾病大鼠降钙素基因相关肽的影响研究 被引量:7

Effects of Puerarin on calcitonin gene-related peptide in DN rats
下载PDF
导出
摘要 目的研究葛根素对糖尿病肾病(DN)大鼠降钙素基因相关肽(CGRP)的影响。方法链脉佐菌素(STZ)诱导糖尿病大鼠模型,随机分为糖尿病组(D组)、葛根素治疗组(S组),同时另设正常对照组(CN组),给药干预14周后,测定空腹血糖(FBG)、尿微量白蛋白(U-mAIb)、血浆内皮素(ET)和CGRP含量。结果糖尿病大鼠UAER增加,ET升高,CGRP下降,给予葛根素治疗14周后,S组DN大鼠U-mAIb较D组显著降低,ET显著下降,CGRP明显升高。结论葛根素对糖尿病大鼠肾脏病变有一定的保护作用,其部分机制可能是通过上调CGRP含量而实现的。 Objective To investigate the effect of Puerarin on calcitonin gene-related peptide in diabetic nephropathy (DN) rats. Methods STZ-indueed diabetic rats were randomly divided into two groups: DN rats model group (D group), puerarin treatment group (S group), in addition, normal rats for control group (CN group). All rats were fed for 14 weeks. The serum FBG, U-mAIb, ET and CGRP were measured. Results Compared with CN group, The content of U-mAIb and ET in DN rats were significantly increased. The level of CGRP was markedly decreased; After the Puerarin treatment, the serum CGRP, ET and U-mAIb changes of diabetic rats in the S group were improved. Conclusion Puerarin could meliorate early kidney hy-perdynamic abnormality in DN rats, possess protective effect on kidney of diabetic rat whose mechanism may be associated partly with a UP-regulation of the CGRP level.
出处 《中国当代医药》 2013年第7期7-8,13,共3页 China Modern Medicine
基金 江西师范大学青年成长基金(No.2399) 江西省亚热带植物资源保护与利用重点实验室基金部分资助项目
关键词 葛根素 糖尿病肾病 降钙素基因相关肽 大鼠 Puerarin Diabetic nephropathy Calcitonin gene-related peptide Rats
  • 相关文献

参考文献11

  • 1Rosenfeld MG, Mermod JJ,Amara SG,et al. Production of a novelneuropeptide encoded by the calcitonin gene via tissue-specific RNAprocessing[J]. Nature,1983,304 (5922) : 129-135.
  • 2Helset E ,Kjaeve J, Bjertnase L,et al. Acute alveolar hypoxia increaseendothelin-1 release but decrease release of calcitonin gene-related pep-tide in isolated perfused rat lungs[J]. Scand JC1 in Lab Invest, 1995,55(5):369-376.
  • 3胡玲,林小红,张选均,顾敏,武亚妮.血浆降钙素相关基因多肽与糖尿病血管病变的关系[J].临床心血管病杂志,1996,12(6):383-384. 被引量:10
  • 4王宪,孙威,邢立愚,宫海滨,郭静萱.糖尿病大鼠肠系膜动脉降钙素基因相关肽释放减少以及一氧化氮的作用[J].生理学报,1998,50(2):206-212. 被引量:8
  • 5Gross JL,Azevedo Mj,Silveiro SP, et al. Diabetic nephropathy: diagno-sis, prevention,and treatment[J]. Diabetic Care,2005,28(1) : 164-176.
  • 6Nozaki K,Okamoto S,Vemura Y,et al. Vaseular relaxation Proportionof Caleitonin gene-related Peptide and vasoaetive intestinal polypep-tide in subarachnoid haemorrhage[J]. J Neurosurg, 1990,72 : 792-797.
  • 7Wang Y, Wang DH. Prevention of endothelin-1 -induced increases inblood pressure : role of endogenous CGRP[J]. Am J Physiol Heart CircPhysiol,2004,287(4) : 1868-74.
  • 8国家药典委员会.中华人民共和国药典[M].一部.广州:广东科技出版社,1995:297.
  • 9苏春晕.实用中药药理新编[M].兰州:甘肃科学技术出版社,1997:179.
  • 10龚志刚,胡红霞,朱笃,张媛.葛根素对糖尿病大鼠血糖和抗氧化能力的影响[J].食品科学,2006,27(11):498-501. 被引量:23

二级参考文献25

  • 1李强翔,钟惠菊,肖扬,李玮,王林娜.葛根素对糖尿病肾病大鼠肾功能的保护作用[J].中国临床康复,2006,10(31):64-66. 被引量:9
  • 2申竹芳 谢明智.葛根素与阿斯匹林复方的降血糖作用[J].药学学报,1985,20(11):863-865.
  • 3TSILIBARY E C. Microvascular basement membranes in diabetes mellitus [ J ]. Pathol, 2003,200 ( 4 ) :537 - 546.
  • 4BANSAL V, KALITA J,MISRA U K. Diabetic neuropathy [J].Postgrad Med J,2006,82 (864) :95 - 100.
  • 5KIKKAWA R,KOYA D, HANED A M. Progression of diabetic neuropathy [ J ]. Am J Kidney Dis, 2003,41 ( Suppl 1 ) : S10 -S13.
  • 6汤健,循环系统的内分泌功能,1989年
  • 7钟学礼,临床糖尿病学,1985年
  • 8Tang Y,Shock,1997年,7卷,225页
  • 9王宪,Br J Pharmacol,1996年,118卷,2164页
  • 10Rittenhouse P A,Peptides,1996年,17卷,1017页

共引文献45

同被引文献193

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部